FDA urges creation of racial, ethnic recruitment plans for clinical trials
The FDA is encouraging drugmakers to create and submit racial and ethnic recruitment plans for clinical trials early in the drug developmant process in an effort to boost participation among underr | The FDA is prioritizing diversity among clinical trial participants in the U.S., with new draft guid...
Comments